Collegium Reports Second Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Collegium Pharma (COLL) Tops Q2 EPS by 5c
August 7, 2019 5:30 PM EDTCollegium Pharma (NASDAQ: COLL) reported Q2 EPS of ($0.14), $0.05 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $75 million versus the consensus estimate of $75.82 million.
Were pleased to report that the growth trajectory for Xtampza® ER remained strong during the first... More
